SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model

By Murray Lesley   Abrams Tinya   Long Kelly   Ngai Theresa   Olson Lisa   Hong Weiru   Keast Paul   Brassard Jacqueline   O’Farrell Anne   Cherrington Julie   Pryer Nancy  

Clinical and Experimental Metastasis, Vol. 20, Iss. 8, 2003-12 ,pp. : 757-766

Springer Publishing Company

Access to resources Recommend Favorite

The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone

By Asanuma Kunihiro  

Breast Cancer, Vol. 20, Iss. 3, 2013-07 ,pp. : 241-246

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer

By                                

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 532-540

Spandidos Publications

Access to resources Recommend Favorite

The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation

By Yao Hongren  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 363-375

Springer Publishing Company

Access to resources Recommend Favorite

Breast cancer bone metastasis and current small therapeutics

By Cicek Muzaffer  

Cancer and Metastasis Reviews, Vol. 25, Iss. 4, 2006-12 ,pp. : 635-644

Springer Publishing Company

Access to resources Recommend Favorite